{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:55:10Z","timestamp":1780077310761,"version":"3.54.0"},"reference-count":108,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T00:00:00Z","timestamp":1608508800000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Agencia Nacional de Investigacion y Desarrollo","award":["Chile: FONDAP 15130011"],"award-info":[{"award-number":["Chile: FONDAP 15130011"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2020,12,7]]},"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:p>SARS-CoV-2 is the virus responsible for the ongoing COVID-19 outbreak. The virus uses ACE2 receptor for viral entry. ACE2 is part of the counter-regulatory renin-angiotensin-aldosterone system and is also expressed in the lower respiratory tract along the alveolar epithelium. There is, however, significant controversy regarding the role of ACE2 expression in COVID-19 pathogenesis. Some have argued that decreasing ACE2 expression would result in decreased susceptibility to the virus by decreasing available binding sites for SARS-CoV-2 and restricting viral entry into the cells. Others have argued that, like the pathogenesis of other viral pneumonias, including those stemming from previous severe acute respiratory syndrome (SARS) viruses, once SARS-CoV-2 binds to ACE2, it downregulates ACE2 expression. Lack of the favourable effects of ACE2 might exaggerate lung injury by a variety of mechanisms. In order to help address this controversy, we conducted a literature search and review of relevant preclinical and clinical publications pertaining to SARS-CoV-2, COVID-19, ACE2, viral pneumonia, SARS, acute respiratory distress syndrome and lung injury. Our review suggests, although controversial, that patients at increased susceptibility to COVID-19 complications may have reduced baseline ACE2, and by modulating ACE2 expression one can possibly improve COVID-19 outcomes. Herein, we elucidate why and how this potential mechanism might work.<\/jats:p>","DOI":"10.1136\/openhrt-2020-001424","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T13:22:56Z","timestamp":1608729776000},"page":"e001424","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":67,"title":["Manipulation of ACE2 expression in COVID-19"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct04312009","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04311177","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04287686","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0951-7279","authenticated-orcid":false,"given":"Farhan","family":"Chaudhry","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lavandero","sequence":"additional","affiliation":[{"name":"Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Quimicas y Farmaceuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile"},{"name":"Internal Medicine (Cardiology Division), University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-4626","authenticated-orcid":false,"given":"Xiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basera","family":"Sabharwal","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Ying","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Affiliated Hospital, Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Correa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Levy","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine and Integrative Biosciences Center, Wayne State University School of Medicine, Detroit, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,12,22]]},"reference":[{"key":"2025081709471201000_7.2.e001424.1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb2507"},{"key":"2025081709471201000_7.2.e001424.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"2025081709471201000_7.2.e001424.3","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-020-0368-x","article-title":"Interaction between RAAS inhibitors and ACE2 in the context of COVID-19","volume":"17","author":"Mourad","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2025081709471201000_7.2.e001424.4","doi-asserted-by":"crossref","unstructured":"Zheng YY , YT M , Zhang JY , et al . COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020.","DOI":"10.1038\/s41569-020-0360-5"},{"key":"2025081709471201000_7.2.e001424.5","doi-asserted-by":"crossref","unstructured":"Vaduganathan M , Vardeny O , Michel T , et al . Renin-Angiotensin-Aldosterone system inhibitors in patients with Covid-19. N Engl J Med 2020.","DOI":"10.1056\/NEJMsr2005760"},{"key":"2025081709471201000_7.2.e001424.6","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"2025081709471201000_7.2.e001424.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.028"},{"key":"2025081709471201000_7.2.e001424.8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"2025081709471201000_7.2.e001424.9","doi-asserted-by":"publisher","DOI":"10.1038\/nature12328"},{"key":"2025081709471201000_7.2.e001424.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9"},{"key":"2025081709471201000_7.2.e001424.11","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa021","article-title":"The reproductive number of COVID-19 is higher compared to SARS coronavirus","volume":"27","author":"Liu","year":"2020","journal-title":"J Travel Med"},{"key":"2025081709471201000_7.2.e001424.12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-Cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front Med"},{"key":"2025081709471201000_7.2.e001424.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41368-020-0074-x"},{"key":"2025081709471201000_7.2.e001424.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x"},{"key":"2025081709471201000_7.2.e001424.15","unstructured":"Guan WJ , ZY N , Hu Y , et al . Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020."},{"key":"2025081709471201000_7.2.e001424.16","doi-asserted-by":"crossref","unstructured":"Sun P , Qie S , Liu Z , et al . Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis. J Med Virol 2020.","DOI":"10.1002\/jmv.25735"},{"key":"2025081709471201000_7.2.e001424.17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"2025081709471201000_7.2.e001424.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41594-019-0334-7"},{"key":"2025081709471201000_7.2.e001424.19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02648-13"},{"key":"2025081709471201000_7.2.e001424.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2015.05.013"},{"key":"2025081709471201000_7.2.e001424.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15562-9"},{"key":"2025081709471201000_7.2.e001424.22","unstructured":"Cheng Y-W , Chao T-L LC-L , et al . Furin inhibitors block SARS-CoV-2 spike protein cleavage to suppress virus production and cytopathic effects. Cell Reports."},{"key":"2025081709471201000_7.2.e001424.23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600640"},{"key":"2025081709471201000_7.2.e001424.24","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"2025081709471201000_7.2.e001424.25","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267"},{"key":"2025081709471201000_7.2.e001424.26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711241105"},{"key":"2025081709471201000_7.2.e001424.27","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"2025081709471201000_7.2.e001424.28","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20040634"},{"key":"2025081709471201000_7.2.e001424.29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2025081709471201000_7.2.e001424.30","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1643-8"},{"key":"2025081709471201000_7.2.e001424.31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/CIRCULATIONAHA.120.047915","article-title":"Differentiating COVID-19 pneumonia from acute respiratory distress syndrome and high altitude pulmonary edema: therapeutic implications","volume":"142","author":"Archer","year":"2020","journal-title":"Circulation"},{"key":"2025081709471201000_7.2.e001424.32","doi-asserted-by":"publisher","DOI":"10.1038\/srep19840"},{"key":"2025081709471201000_7.2.e001424.33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4595"},{"key":"2025081709471201000_7.2.e001424.34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900579"},{"key":"2025081709471201000_7.2.e001424.35","doi-asserted-by":"publisher","DOI":"10.1038\/srep08209"},{"key":"2025081709471201000_7.2.e001424.36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","article-title":"Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation","volume":"43","author":"Li","year":"2015","journal-title":"Shock"},{"key":"2025081709471201000_7.2.e001424.37","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/CIRCULATIONAHA.120.047297","article-title":"Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?","volume":"141","author":"Peir\u00f3","year":"2020","journal-title":"Circulation"},{"key":"2025081709471201000_7.2.e001424.38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"2025081709471201000_7.2.e001424.39","doi-asserted-by":"crossref","unstructured":"Zhang C , Wu Z , JW L , et al . The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) antagonist tocilizumab may be the key to reduce the mortality. Int J Antimicrob Agents 2020;105954.","DOI":"10.1016\/j.ijantimicag.2020.105954"},{"key":"2025081709471201000_7.2.e001424.40","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00011-020-01342-0","article-title":"The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients","volume":"69","author":"Yuan","year":"2020","journal-title":"Inflamm Res"},{"key":"2025081709471201000_7.2.e001424.41","doi-asserted-by":"publisher","DOI":"10.1186\/cc1843"},{"key":"2025081709471201000_7.2.e001424.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.03.004"},{"key":"2025081709471201000_7.2.e001424.43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"2025081709471201000_7.2.e001424.44","unstructured":"Dexamethasone in hospitalized patients with Covid-19 \u2014 preliminary report. New England Journal of Medicine 2020."},{"key":"2025081709471201000_7.2.e001424.45","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000181529.08630.49"},{"key":"2025081709471201000_7.2.e001424.46","doi-asserted-by":"crossref","unstructured":"Wu C , Chen X , Cai Y , et al . Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020.","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"2025081709471201000_7.2.e001424.47","unstructured":"WHO . Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 2020."},{"key":"2025081709471201000_7.2.e001424.48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"2025081709471201000_7.2.e001424.49","doi-asserted-by":"crossref","unstructured":"Xu Z , Shi L , Wang Y , et al . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020.","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"2025081709471201000_7.2.e001424.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.02.01"},{"key":"2025081709471201000_7.2.e001424.51","first-page":"75","article-title":"Evolution of pulmonary pathology in severe acute respiratory syndrome","volume":"104","author":"Hsiao","year":"2005","journal-title":"J Formos Med Assoc"},{"key":"2025081709471201000_7.2.e001424.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61515-3"},{"key":"2025081709471201000_7.2.e001424.53","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.chest.2019.10.032","article-title":"Viral infection increases the risk of idiopathic pulmonary fibrosis: a meta-analysis","volume":"157","author":"Sheng","year":"2020","journal-title":"Chest"},{"key":"2025081709471201000_7.2.e001424.54","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.6.2119"},{"key":"2025081709471201000_7.2.e001424.55","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.030205"},{"key":"2025081709471201000_7.2.e001424.56","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(96)00007-4"},{"key":"2025081709471201000_7.2.e001424.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.genm.2011.12.003"},{"key":"2025081709471201000_7.2.e001424.58","doi-asserted-by":"publisher","DOI":"10.1177\/1535370217718808"},{"key":"2025081709471201000_7.2.e001424.59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1271"},{"key":"2025081709471201000_7.2.e001424.60","unstructured":"JT W , Leung K , Bushman M , et al . Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine 2020."},{"key":"2025081709471201000_7.2.e001424.61","unstructured":"Yang J , Zheng Y , Gou X , et al . Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J Infect Dis 2020."},{"key":"2025081709471201000_7.2.e001424.62","first-page":"20025031","article-title":"A descriptive study of the impact of diseases control and prevention on the epidemics dynamics and clinical features of SARS-CoV-2 outbreak in Shanghai, lessons learned for metropolis epidemics prevention","volume":"2020.2002.2019","author":"Lu","year":"2020","journal-title":"medRxiv"},{"key":"2025081709471201000_7.2.e001424.63","doi-asserted-by":"publisher","DOI":"10.1111\/all.14238"},{"key":"2025081709471201000_7.2.e001424.64","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112148-20200220-00105"},{"key":"2025081709471201000_7.2.e001424.65","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"2025081709471201000_7.2.e001424.66","doi-asserted-by":"publisher","DOI":"10.1038\/nature00786"},{"key":"2025081709471201000_7.2.e001424.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.064"},{"key":"2025081709471201000_7.2.e001424.68","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckx130"},{"key":"2025081709471201000_7.2.e001424.69","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2213-2600(20)30117-X","article-title":"Sex difference and smoking predisposition in patients with COVID-19","volume":"8","author":"Cai","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025081709471201000_7.2.e001424.70","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047"},{"key":"2025081709471201000_7.2.e001424.71","doi-asserted-by":"crossref","unstructured":"Cai G . Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv 2020:2020.2002.2005.20020107.","DOI":"10.20944\/preprints202002.0051.v3"},{"key":"2025081709471201000_7.2.e001424.72","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030841","article-title":"Smoking upregulates angiotensin-converting enzyme-2 receptor: a potential adhesion site for novel coronavirus SARS-CoV-2 (Covid-19)","volume":"9","author":"Brake","year":"2020","journal-title":"J Clin Med"},{"key":"2025081709471201000_7.2.e001424.73","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.9.3243"},{"key":"2025081709471201000_7.2.e001424.74","doi-asserted-by":"crossref","unstructured":"Wu X , Nethery RC , Sabath BM , et al . Exposure to air pollution and COVID-19 mortality in the United States. medRxiv 2020:2020.2004.2005:20054502.","DOI":"10.1289\/isee.2020.virtual.O-OS-638"},{"key":"2025081709471201000_7.2.e001424.75","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00048.2007"},{"key":"2025081709471201000_7.2.e001424.76","doi-asserted-by":"crossref","DOI":"10.1186\/s12989-015-0094-4","article-title":"Acute and subchronic exposure to air particulate matter induces expression of angiotensin and bradykinin-related genes in the lungs and heart: angiotensin-II type-I receptor as a molecular target of particulate matter exposure","volume":"12","author":"Aztatzi-Aguilar","year":"2015","journal-title":"Part Fibre Toxicol"},{"key":"2025081709471201000_7.2.e001424.77","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.23489"},{"key":"2025081709471201000_7.2.e001424.78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiaa332","article-title":"ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19","volume":"222","author":"Pinto","year":"2020","journal-title":"J Infect Dis"},{"key":"2025081709471201000_7.2.e001424.79","doi-asserted-by":"crossref","unstructured":"Guan WJ , Liang WH , Zhao Y , et al . Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. Eur Respir J 2020.","DOI":"10.1183\/13993003.01227-2020"},{"key":"2025081709471201000_7.2.e001424.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.03.019"},{"key":"2025081709471201000_7.2.e001424.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2004.10.010"},{"key":"2025081709471201000_7.2.e001424.82","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000244543.91937.79"},{"key":"2025081709471201000_7.2.e001424.83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.02.088"},{"key":"2025081709471201000_7.2.e001424.84","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03743"},{"key":"2025081709471201000_7.2.e001424.85","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"2025081709471201000_7.2.e001424.86","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis733"},{"key":"2025081709471201000_7.2.e001424.87","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/COPD.S158634","article-title":"Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD","volume":"13","author":"Lai","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025081709471201000_7.2.e001424.88","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40842-017-0044-1","article-title":"Renin angiotensin system-modifying therapies are associated with improved pulmonary health","volume":"3","author":"Soto","year":"2017","journal-title":"Clin Diabetes Endocrinol"},{"key":"2025081709471201000_7.2.e001424.89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1995.tb16357.x"},{"key":"2025081709471201000_7.2.e001424.90","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000187500.24964.7A"},{"key":"2025081709471201000_7.2.e001424.91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejphar.2013.08.019","article-title":"Mineralocorticoid receptor antagonists attenuate pulmonary inflammation and bleomycin-evoked fibrosis in rodent models","volume":"718","author":"Lieber","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"2025081709471201000_7.2.e001424.92","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14105","article-title":"Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1-7)\/MAS receptor axes in human mesangial cells","volume":"7","author":"Stoll","year":"2019","journal-title":"Physiol Rep"},{"key":"2025081709471201000_7.2.e001424.93","first-page":"891","article-title":"[Aliskiren inhibits angiotensin II\/angiotensin 1-7(Ang II\/Ang1-7) signal pathway in rats with diabetic nephropathy]","volume":"34","author":"Ding","year":"2018","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"2025081709471201000_7.2.e001424.94","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01337"},{"key":"2025081709471201000_7.2.e001424.95","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201205-0880OC"},{"key":"2025081709471201000_7.2.e001424.96","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/qjmed\/hcz206","article-title":"Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-\u03baB and Nrf2 pathways","volume":"112","author":"Fang","year":"2019","journal-title":"QJM"},{"key":"2025081709471201000_7.2.e001424.97","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1823-x"},{"key":"2025081709471201000_7.2.e001424.98","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cell.2020.04.004","article-title":"Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2","volume":"181","author":"Monteil","year":"2020","journal-title":"Cell"},{"key":"2025081709471201000_7.2.e001424.99","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05985-9"},{"key":"2025081709471201000_7.2.e001424.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.11.013"},{"key":"2025081709471201000_7.2.e001424.101","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","article-title":"Viral dynamics in mild and severe cases of COVID-19","volume":"20","author":"Liu","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025081709471201000_7.2.e001424.102","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30354-4","article-title":"SARS-CoV-2 viral load predicts COVID-19 mortality","volume":"8","author":"Pujadas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025081709471201000_7.2.e001424.103","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 \u2014 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025081709471201000_7.2.e001424.104","article-title":"Risk of adverse outcomes in hospitalized patients with autoimmune disease and COVID-19: a matched cohort study from New York City","author":"Faye","year":"2020","journal-title":"J Rheumatol"},{"key":"2025081709471201000_7.2.e001424.105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117147","article-title":"COVID-19 in multiple sclerosis patients and risk factors for severe infection","volume":"418","author":"Chaudhry","year":"2020","journal-title":"J Neurol Sci"},{"key":"2025081709471201000_7.2.e001424.106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923"},{"key":"2025081709471201000_7.2.e001424.107","doi-asserted-by":"publisher","DOI":"10.1177\/1535370216665174"},{"key":"2025081709471201000_7.2.e001424.108","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2020-0727"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2020-001424","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:47:28Z","timestamp":1755449248000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2020-001424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":108,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,12,22]]},"published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1136\/openhrt-2020-001424"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2020-001424","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]}}}